(S (NP (NP (DT The) (NNS mutations)) (PP (IN of) (NP (NP (DT a) (JJ complex) (JJ systemic) (NN disease)) (PP (IN like) (NP (NN cancer)))))) (VP (MD can) (VP (VB be) (VP (VBN modeled) (PP (IN as) (NP (NP (JJ stuck-at) (NNS faults)) (PP (IN in) (NP (DT the) (NNP Boolean) (NN system) (NN paradigm)))))))) (. .))
(S (PP (IN For) (NP (NP (DT a) (NN class)) (PP (IN of) (NP (JJ multiple) (NNS faults))))) (, ,) (NP (DT the) (NN fault) (NN identification)) (VP (VBZ is) (ADJP (RB exceptionally) (JJ significant)) (PP (IN under) (NP (NP (DT the) (JJ incomplete) (NN access)) (PP (IN of) (NP (NP (PDT all) (DT the) (JJ underlying) (NNS proteins)) (PP (IN of) (NP (DT the) (NN system)))))))) (. .))
(S (NP (DT A) (JJ comprehensive) (NN linear) (NN framework)) (VP (VBZ has) (VP (VBN been) (VP (VBN developed) (PP (IN in) (NP (DT this) (NN manuscript))) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (NNS faults))) (PP (IN under) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (JJ homeostatic) (NN input) (NNS conditions)))))))))))) (. .))
(S (NP (DT An) (NN algorithm)) (VP (VBZ is) (VP (VBN developed) (S (VP (TO to) (VP (VB design) (NP (JJ new) (NNS reporters)) (SBAR (S (VP (TO to) (VP (VB improve) (NP (DT the) (NN observability))))))))))) (. .))
(S (NP (NP (DT The) (JJ other) (NN aspect)) (PP (IN of) (NP (DT this) (NN manuscript)))) (VP (VBZ lies) (PP (IN in) (S (VP (VP (VBG controlling) (NP (NP (DT the) (NN manifestation)) (PP (IN of) (NP (DT the) (NNS mutations))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (JJ essential) (NN objective)) (PP (IN of) (NP (NNS systems) (JJ medicine) (NN research))))))))))) (. .))
(S (NP (DT The) (JJ primary) (NN goal)) (VP (VBZ is) (S (VP (TO to) (VP (VB synthesize) (NP (NP (NP (DT a) (NN cocktail)) (PP (IN of) (NP (NN drug) (NNS molecules)))) (PRN (-LRB- -LRB-) (NP (NN combination) (NN therapy)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (VBG existing) (VBN targeted) (NNS drugs))))))))) (. .))
(S (NP (DT The) (NN controllability) (NNS results)) (VP (VBP are) (VP (VBN included) (PP (IN in) (NP (DT this) (NN paper))) (S (VP (TO to) (VP (VB understand) (NP (DT the) (NN problem)) (ADVP (RB formally))))))) (. .))
(S (NP (NP (DT An) (NN improvement)) (PP (IN of) (NP (NN controllability) (NN algorithm)))) (VP (VBZ is) (VP (VBN discussed) (S (VP (TO to) (VP (VB design) (NP (JJ new) (NN target) (NNS drugs)) (SBAR (IN if) (S (NP (DT the) (JJ available) (NNS drugs)) (VP (VBP fail) (S (VP (TO to) (VP (VB accommodate) (NP (DT the) (JJ underlying) (NN fault) (VBN set))))))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP are) (VP (VBN presented) (PP (IN for) (NP (NP (NNP Boolean) (NNS maps)) (CC and) (NP (NNP Boolean) (NN control) (NNS networks)))))) (. .))
(S (NP (JJ Biological) (NNS examples)) (VP (VBP are) (VP (VBN given) (S (VP (TO to) (VP (VB highlight) (NP (DT the) (JJ relevant) (NNS results))))))) (. .))
